We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.
- Authors
Farkouh, M E; Greenberg, J D; Jeger, R V; Ramanathan, K; Verheugt, F W A; Chesebro, J H; Kirshner, H; Hochman, J S; Lay, C L; Ruland, S; Mellein, B; Matchaba, P T; Fuster, V; Abramson, S B
- Abstract
Evidence suggests that both selective cyclooxygenase (COX)-2 inhibitors and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of cardiovascular events. However, evidence from prospective studies of currently available COX-2 inhibitors and non-selective NSAIDs is lacking in patients at high cardiovascular risk who are taking aspirin.
- Publication
Annals of the rheumatic diseases, 2007, Vol 66, Issue 6, p764
- ISSN
0003-4967
- Publication type
Journal Article
- DOI
10.1136/ard.2006.066001